An Incisive, In-depth Analysis on the Digital Breast Tomosynthesis Dbt System Market
This study offers a comprehensive, 360 degree analysis on the Digital Breast Tomosynthesis Dbt System market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Digital Breast Tomosynthesis Dbt System market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Digital breast tomosynthesis (DBT) is a 3D breast imaging technique built on full field digital mammography technology. DBT systems creates multiple projection images of the breasts obtained from different angles of the rotating X-Ray tube at a low radiation dose through the compressed breast. Images are reconstructed into multiple slices of 1mm thickness and viewed on a dedicated monitor approved for tomosynthesis. This minimises the impact of tissue superimposition resulting in better visualisation of the internal structures. Conventionally, breast screening was performed step by step, starting with full-field digital mammography (FFDM or 2D mammography) followed by digital breast tomosynthesis (3D mammography) or breast Magnetic Resonance Imaging (MRI). FFDM is considered the gold standard in breast cancer screening. However, with the advent of DBT technology, it is slowly being replaced. DBT is frequently used as an adjunct technique with FFDM. Research and studies are being undertaken to consider DBT as a primary screening tool, particularly in patients with dense breasts. 3D mammography has proven to be better than 2D mammography in multiple clinical trials, which has led to an increase in its adoption. Combination of 2D and 3D mammography has become the new standard of care since 3D mammography compliments conventional 2D mammography.
Market Value and Forecast
The global digital breast tomosynthesis equipment market was valued at US$ 886.6 Mn in 2015, and is projected to expand at a CAGR of 13.9% over forecast period 2016–2026. Increasing adoption of 3D mammography due to superior features over 2D mammography and favourable regulatory backing are factors fuelling market growth across the globe. The digital breast tomosynthesis equipment market would be driven by both new equipment purchases and upgradation of existing digital mammography machines.
Drivers and Trends
Risk of developing cancer is directly proportional to age. Increasing life expectancy in developing countries and adoption of unhealthy lifestyles due to rampant urbanisation and westernisation are driving incidence rate of cancer among the population in these countries. Although, incidence of breast cancer has reduced in developed countries due to several preventive measures implemented by various government and non-governmental organisations, incidence rate of breast cancer is increasing at a steady rate. These factors are expected to increase the prevalence and diagnosis of breast cancer over the forecast period. DBT machines, with their superior sensitivity and specificity in comparison to conventional 2D mammography, reduces false positive recalls and offers better cancer detection especially, invasive cancer detection. DBT reduces the need to revisit for additional breast imaging by around 15%, thereby reducing costs, psychological distress, time and discomfort caused by a false negative recall. DBT equipment manufacturers are providing software and hardware upgrades for existing full film digital mammography systems which addresses the financial impact of buying new equipment.
Analysis by End User
By end user, the global digital breast tomosynthesis equipment market is segmented into hospitals and diagnostic centres. In terms of revenue, hospitals segment is expected to expand at a CAGR of 14.9% during the forecast period.
Analysis by Region
On the basis of geography, the digital breast tomosynthesis equipment market has been segmented into seven major regions namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa (MEA). In terms of value, North America market has been estimated to dominate the global digital breast tomosynthesis equipment market in 2016 and is expected to witness the highest CAGR of 2.4% over the forecast period. The digital breast tomosynthesis equipment markets in MEA, North America and Western Europe are estimated to register higher CAGRs as compared to other regional markets. In terms of value, North America market is expected to expand at a CAGR of 14.5% over the forecast period. New equipment sales in the North America market is expected to register a CAGR of 16.0% during the forecast period and is expected to be valued at US$ 2.1 Bn by 2026 end.
Some of the key players identified in the global digital breast tomosynthesis equipment market report include Hologic Inc., Siemens Healthineers, Fujifilm Corporation, GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed OY The report offers valuable insights into company-specific strategies, market consolidation initiatives and analyses of the various market players’ specific strengths, weaknesses, opportunities and threats related to the global digital breast tomosynthesis equipment market.
In this report, Future Market Insights (FMI) offers a 10-year forecast (2016–2026) of the digital breast tomosynthesis (DBT) equipment market. In terms of value, the digital breast tomosynthesis equipment market is expected to register a CAGR of 13.9% during the forecast period. This study demonstrates market dynamics and trends in major countries and regions, which are expected to influence the current environment and future status of the digital breast tomosynthesis equipment market over the forecast period.
This report examines the global digital breast tomosynthesis equipment market for the period 2016-2026.
The primary objective of the report is to offer insights into advancements in the digital breast tomosynthesis equipment market that are significantly helping transform the breast imaging market.
The digital breast tomosynthesis equipment market report begins by defining mammography and its types. It also lists the various mammography techniques. This is followed by an overview of the global digital breast tomosynthesis equipment market. The overview section includes FMI’s analysis of key trends, drivers, restraints and opportunities influencing growth of the global digital breast tomosynthesis equipment market. Impact analysis of key growth drivers and restraints based on the weighted average model has also been included in the report to better equip clients with country-specific trends and insights.
Rising incidence of breast cancer in developing countries with increasing life expectancy and increasing adoption of unhealthy lifestyles are primary factors driving growth of the digital breast tomosynthesis equipment. Hospitals and diagnostic centres are upgrading their existing digital mammography machines and installing new DBT equipment due to increasing evidences about effective combination of 2D and 3D mammography in cancer detection and reducing false positive call-backs. Combination of 2D and 3D mammography has become the new standard of care, since 3D mammography compliments conventional 2D mammography.
On the basis of product type, the market has been segmented into DBT equipment and 3D upgradation. A detailed analysis of all categories by product type, has been provided in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
On the basis of end user, the report has been segmented into hospitals and diagnostic centres. A detailed analysis of all categories by end user, has been provided in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
The following section of the report highlights the global digital breast tomosynthesis equipment market by region. It provides a market outlook for 2016–2026 and sets the forecast within the context of the digital breast tomosynthesis equipment market. The study discusses the key regional trends contributing to growth of the digital breast tomosynthesis equipment market across the globe. It also analyses the degree to which global drivers are influencing this market in each regions.
Key markets assessed in this report include North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA).
The above sections - by product type, end user type and region — evaluate the present scenario and growth prospects of the digital breast tomosynthesis equipment market for the period 2016-2026. We have considered 2015 as the base year and provided data for the forecast period, i.e. 2016-2026.
The forecast presented here assesses the total revenue generated across the digital breast tomosynthesis equipment market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the digital breast tomosynthesis equipment market would develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis, i.e. by supply side, downstream industry demand and economic envelope.
It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters such as Year-On-Year (Y-o-Y) growth rates, to understand the predictability of the global digital breast tomosynthesis equipment market and to identify the right opportunities the market presents.
The global digital breast tomosynthesis equipment market segments in terms of product type, end user type and regional presence are analysed on the basis of their respective Basis Point (BPS) to understand the individual segment’s relative contribution to market growth. This detailed level of information is important for identification of various key trends in the respective market.
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective.
To understand key growth segments, FMI has developed the market ‘Attractiveness Index’. The resulting index would help providers to identify real market opportunities.
In the final section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, to get a firm understanding of the key differentiators among competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the digital breast tomosynthesis equipment value chain and the potential players with regard to the same. This section also includes market strategies and SWOT analysis of the main players in the market.
Detailed profiles of the digital breast tomosynthesis equipment companies are also included in the scope of the report to evaluate their long- and short-term strategies. Key players in the market include Hologic Inc., Siemens Healthineers, Fujifilm Corporation, GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed OY
Key Segments Covered
By Product type
- DBT Equipment
- 3-D Upgradation
By End User
- Diagnostic centres
Key Regions Covered
- North America
- Latin America
- Western Europe
- Eastern Europe
- Hologic Inc.
- Siemens Healthineers
- Fujifilm Corporation
- GE Healthcare
- Internazionale Medico Scientifica S.r.l.
- Planmed OY